跳至主要内容
临床试验/NCT01735136
NCT01735136已完成不适用

Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection

Chonbuk National University Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Changes in 14C-UBT(Urea breath test)

研究概览

简要总结

The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of InSan Bamboo Salt on improvement of Helicobacter pylori infection. The investigators measured improvement of Helicobacter pylori infection parameters , including 14C-UBT(Urea breath test), and subjects' symptoms, and monitored their blood pressure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Males and females 19-65 years old
  • •14C-UBT test ≥ 100 cpm
  • •Endoscopy results showing gastritis
  • •Able to give informed consent

排除标准

  • •Diagnosed of gastrointestinal disease such as ulcer, cancer, more than 10 erosions
  • •Taken antibiotics and stomach medicines such as steroid, bismuth compound, H2-receptor antagonist and proton pump inhibitor within 2 weeks
  • •Allergic or hypersensitive to any of the ingredients in the test products
  • •History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • •History of alcohol or substance abuse
  • •Participation in any other clinical trials within past 2 months
  • •Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • •Pregnant or lactating women etc.

研究组 & 干预措施

InSan Bamboo Salt

Experimental

干预措施: InSan Bamboo Salt (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes in 14C-UBT(Urea breath test)

时间窗: 4 weeks

14C-UBT(Urea breath test) was measured in study visit 1(0 week) and visit 3(4 week).

次要结局

  • Changes in subjects' symptoms(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (1)

Loading locations...

相似试验